Future fertility is often a primary concern for those newly diagnosed with cancer. Options for fertility preservation vary by age and sex, but cryopreservation of sperm, oocytes and embryos is an effective alternative for post-pubertal patients.

New technologies have made endoscopic management of BE-related dysplasia and early cancer the standard of care for many patients, who return home the day the cancer is removed, eat a regular diet and have a normal quality of life.

Research shows that a less invasive procedure known as sentinel lymph node surgery successfully identified whether cancer remained in lymph nodes in 91 percent of patients with node-positive breast cancer who received chemotherapy before their surgery.

Xenografted cells generate tumors that maintain morphological, molecular and histopathologic features of human tumors
Mayo laboratories were one of the first to implant human tumor specimens directly in animal models to generate in vivo cell lines. Its researchers have developed more than 50 glioblastoma xenograft models.

Gene expression profiling identifies women in whom breast cancer tumors will return
A research team led by oncologists at Mayo Clinic in Florida discovered 27 genes significantly associated with a good outcome with concurrent use of trastuzumab and chemotherapy and five genes linked to poor outcomes.

Diabetes drug metformin shows promise for treatment of ovarian cancer
Researchers found that patients with diabetes and ovarian cancer who took metformin for their diabetes had a better cancer survival rate than patients who did not take it. Metformin has also shown promise for treatment of other cancers.

Individualized Breast, GYN, and Colon Cancer Management
Feb. 15-16, 2013, in Jacksonville, Fla.
Subtitled New Data and Updates Relevant to Patient Care, this course focuses on screening, diagnosis and treatment, management guidelines, molecular diagnosis, and individualized therapy based on molecular profiles. A special session on supportive care emphasizes optimal surveillance after treatment for malignancies.

Mayo Clinic Oncology Review
July 20, 2013, in Minneapolis
Invited speakers discuss abstracts presented at the American Society of Clinical Oncology June 2013 annual meeting and their clinical relevance to the practice of oncology. Additional topics include recent advances in the treatment of various oncologic malignancies.

See all Hematology & Oncology Continuous Professional Development courses

New Grand Rounds presentations are available online

Martin Bues, Ph.D.
Radiation Oncology in Arizona

Stephanie K. Childs, M.D.
Radiation Oncology in Minnesota

Thorvardur R. Halfdanarson, M.D.
Hematology/Oncology in Arizona

Prashant Kapoor, M.D.
Hematology in Minnesota

Arleigh McCurdy, M.D.
Hematology in Minnesota

Robert W. Mutter, M.D.
Radiation Oncology in Minnesota

Deanna H. Pafundi, Ph.D.
Radiation Oncology in Minnesota

Steven I. Robinson, MBBS
Oncology in Minnesota

Mustaqeem A. Siddiqui, MBBS
Hematology in Minnesota

Stephan D. Thome, M.D.
Oncology in Minnesota

• Mayo Clinic in Arizona
  866-629-6362 (toll-free)
• Mayo Clinic in Florida
  800-634-1417 (toll-free)
• Mayo Clinic in Minnesota
  800-533-1564 (toll-free)
• Online Referrals

• Physician Update Video Blog
• Clinical Trials at Mayo Clinic
• Mayo School of Continuous Professional Development